Company Filing History:
Years Active: 2018-2019
Title: Innovations and Contributions of Inventor Ali Riazi
Introduction
Ali Riazi is a notable inventor based in Thornhill, Canada, recognized for his significant contributions to the field of immunology with a focus on combating bacterial infections. With a remarkable portfolio of two patents, he has made strides in addressing critical health issues caused by pathogenic bacteria.
Latest Patents
His latest patent, titled "Anti-campylobacter jejuni antibodies and uses therefor," targets Campylobacter jejuni, a leading cause of bacterial food-borne diseases in humans. This invention outlines an isolated or purified antibody or its fragment, which binds to a flagellar protein, thereby reducing the motility of the bacterium. The developed antibody or fragment is derived from a heavy chain IgG variable domain fragment (VH) obtained from a camelid animal that has been immunized with the flagellar protein. Additionally, this patent includes a multivalent form, as well as a phage format of the antibody. It describes methods for reducing the presence of Campylobacter jejuni in animals or their environments, and provides formulations for treating infections and methods for detection.
Career Highlights
Ali Riazi is affiliated with the National Research Council of Canada, where he applies his skills and knowledge to develop groundbreaking solutions in health and safety. His work is pivotal in advancing research that can lead to innovative therapies that address food safety and public health concerns.
Collaborations
Throughout his career, Riazi has collaborated with esteemed colleagues, including Mehdi Arbabi Ghahroudi and Christine M Szymanski. These collaborations significantly enhance the depth and breadth of his research, contributing to the advancement of innovative medical solutions.
Conclusion
Ali Riazi exemplifies the spirit of innovation that drives improvements in public health through his dedicated research and patented inventions. His work in developing anti-Campylobacter jejuni antibodies not only showcases his expertise but also reflects a commitment to addressing serious health challenges faced by society today.